Dendreon’s Provenge Has Positive Results
Published by Live Search News: "Food and Drug Administration" November 8th, 2006 in Regulatory AffairsMSN MoneyCentral - Protect has been given fast-track status by the Food and Drug Administration, allowing the company to submit data in an ongoing basis. Prostate cancer is the most common non-skin cancer in the United States and the third most common worldwide. “The …